Home › Funds › Rock Springs Capital Management LP › TVTX

Rock Springs Capital Management LP position in TVTX

TRAVERE THERAPEUTICS INC · Health Care

Rock Springs Capital Management LP reported holding 2,204,085 shares of TVTX (TRAVERE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$129.8M, representing 7.02% of its reported portfolio and ranking #2 among its reported holdings. Rock Springs Capital Management LP has disclosed TVTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.20M sh
Reported value held$129.78M
Portfolio Weight7.02%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Rock Springs Capital Management LP's TVTX position evolved

Rock Springs Capital Management LP first disclosed a stake in TVTX in Q3 2023 at 3,250,000 shares (US$2.7M). The position peaked in Q3 2026 at 2,204,085 shares, worth US$129.8M. Across 13 filings, Rock Springs Capital Management LP increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 2,204,085 shares valued at US$129.8M — an increase of 25,016 shares quarter over quarter.. Notable position changes include a 44% increase in Q3 2024 (shares rose 25% over the following quarter), a 41% trim in Q1 2025 (shares fell 17% over the following quarter), a 47% increase in Q2 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.25M $2.68M New
Q4 2023 3.25M $2.77M Hold
Q1 2024 3.25M $2.84M Hold
Q2 2024 3.25M $2.89M Hold
Q3 2024 4.68M $65.54M Add
Q4 2024 4.97M $86.64M Add
Q1 2025 2.92M $52.35M Reduce
Q2 2025 1.91M $28.24M Reduce
Q3 2025 2.16M $51.74M Add
Q4 2025 2.21M $84.46M Add
Q1 2026 1.48M $43.91M Reduce
Q2 2026 2.18M $123.79M Add
Q3 2026 2.20M $129.78M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TVTX and 13F data

TVTX (TRAVERE THERAPEUTICS INC) is a Health Care company. 54 other funds we track also report a position in TVTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$213.2M), Kynam Capital Management, LP (US$117.8M), Stephens Investment Management Group LLC (US$110.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TVTX

All TVTX fund holders →

FAQ

How long has Rock Springs Capital Management LP held TVTX?

Rock Springs Capital Management LP has disclosed TVTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Rock Springs Capital Management LP's current position in TVTX?

As of Q3 2026, Rock Springs Capital Management LP holds 2.20M shares of TVTX (TRAVERE THERAPEUTICS INC), valued at $129.78M, representing 7.02% of its reported portfolio and ranking #2.

Has Rock Springs Capital Management LP been buying or selling TVTX?

In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP increased its position in TVTX. The position peaked in Q3 2026 at 2.20M shares.

Which other funds hold TVTX?

Other major institutional holders of TVTX include PERCEPTIVE ADVISORS LLC, Kynam Capital Management, LP, Stephens Investment Management Group LLC, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.